Company profile
LiVET AG
We develop and produce rapid molecular point-of-care diagnostic tests for veterinary use. Based on our proprietary platform technology, veterinarians are able to diagnose infectious disease on-site and within only 30 minutes for up to 16 samples at once. This allows for immediate and specific treatment. Our first multiplex panel test for respiratory diseases in horses will be available by summer 2020. We aim to change the way of thinking about diagnostics in the veterinary market, implementing point-of-care testing as the new standard. By bringing the application of specialized laboratories closer to the patients we strive to increase the quality of animal health care.
Source: startup.ch